Volume 13, Number 6 (Aug 2022)

Editorial

2022 ASCO Annual Meeting: Takeaways for the Advanced Practitioner

Welcome to our special issue on highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. Taking place from June 3 to 7, 2022, oncology professionals from around the world convened in Chicago to discuss the la...

August 22, 2022

Meeting Report

Breast Cancer: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner

Jacquelyn Lauria, RN, APN, AOCNP®, of Rutgers Cancer Institute, discusses results from the DESTINY-BREAST04 trial on HER2-low metastatic breast cancer, findings on sacituzumab govitecan in HR-positive, HER2-negative metastatic breast can...

August 23, 2022

Meeting Report

Thoracic Cancer: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner

Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC, of MD Anderson Cancer Center, reviews research in thoracic cancers presented at the 2022 ASCO Annual Meeting, including neoadjuvant immunotherapy for resectable stage IIIA non–small cell lung ...

August 23, 2022

Meeting Report

Gastrointestinal Cancer: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner

Nina N. Grenon, DNP, AGCNP-BC, AOCN®, of Dana-Farber Cancer Institute, evaluates data on RAS wild-type metastatic colorectal cancer, locally advanced mismatch repair–deficient rectal cancer, circulating tumor DNA tests, pancreatic neuroe...

August 23, 2022

Meeting Report

Genitourinary Cancer: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner

Emily Lemke, DNP, AGPCNP-BC, AOCNP®, of the Medical College of Wisconsin Cancer Center, comments on MET and CTLA-4 inhibitors for clear cell renal cell carcinoma, maintenance targeted therapy for patients with metastatic urothelial carci...

August 24, 2022

Meeting Report

Gynecologic Cancer: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner

Laura Doherty, FNP-BC, AOCNP®, of Women & Infants Hospital/Brown University, interprets data presented at the 2022 ASCO Annual Meeting on rucaparib maintenance in advanced ovarian cancer, single-agent trabectedin in BRCA-positive ova...

August 24, 2022

Meeting Report

Melanoma: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner

Suzanne McGettigan, MSN, CRNP, AOCN®, of Abramson Cancer Center of the Hospital of the University of Pennsylvania, reviews data on adjuvant therapy in stage IIB or IIC melanoma and omitting lymph node dissection and adjuvant therapy in p...

August 24, 2022

Meeting Report

Head and Neck Cancer: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner

Heidi Mason, DNP, ACNP-BC, of the University of Michigan School of Nursing, considers research on avoiding concurrent chemotherapy in patients with nasopharyngeal carcinoma being treated with radiotherapy and a clinical trial on concurre...

August 24, 2022

Meeting Report

Hematologic Malignancies: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner

P. Andrew Allred, MS, PA-C, of Banner MD Anderson Cancer Center, considers data on managing newly diagnosed MM and CAR T-cell therapy in MM. Amy Pierre, MSN, ANP-BC, of MSKCC and Flatiron Health, reviews findings on telemedicine inequiti...

August 24, 2022

Meeting Report

The AP Role in Clinical Research: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner

Elizabeth Koselke, PharmD, BCOP, of The US Oncology Network, describes a clinical pharmacist intervention to screen patients and improve clinical trial enrollment. Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP®, of the University of Haw...

August 24, 2022